Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2002 5
2003 13
2004 16
2005 22
2006 27
2007 32
2008 43
2009 56
2010 49
2011 80
2012 83
2013 97
2014 126
2015 125
2016 100
2017 131
2018 137
2019 123
2020 181
2021 183
2022 21
Text availability
Article attribute
Article type
Publication date

Search Results

1,465 results
Results by year
Filters applied: . Clear all
Page 1
Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer.
Mok TS, Wu Y-L, Ahn M-J, Garassino MC, Kim HR, Ramalingam SS, Shepherd FA, He Y, Akamatsu H, Theelen WS, Lee CK, Sebastian M, Templeton A, Mann H, Marotti M, Ghiorghiu S, Papadimitrakopoulou VA; AURA3 Investigators. Mok TS, et al. Among authors: he y. N Engl J Med. 2017 Feb 16;376(7):629-640. doi: 10.1056/NEJMoa1612674. Epub 2016 Dec 6. N Engl J Med. 2017. PMID: 27959700 Free PMC article. Clinical Trial.
ALDH2 deficiency promotes alcohol-associated liver cancer by activating oncogenic pathways via oxidized DNA-enriched extracellular vesicles.
Seo W, Gao Y, He Y, Sun J, Xu H, Feng D, Park SH, Cho YE, Guillot A, Ren T, Wu R, Wang J, Kim SJ, Hwang S, Liangpunsakul S, Yang Y, Niu J, Gao B. Seo W, et al. Among authors: he y. J Hepatol. 2019 Nov;71(5):1000-1011. doi: 10.1016/j.jhep.2019.06.018. Epub 2019 Jul 4. J Hepatol. 2019. PMID: 31279903 Free PMC article.
1,465 results